Announced Thu, 27 Aug, 2026 · 19:27 IST
Hester Biosciences gets credit rating upgrade from CARE Ratings
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.1%1-day move
₹2304.00
prior close
₹2294.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.5+2.0+1.9+1.5-2.1-3.9-5.0-5.2+4.2+1.8-5.1-7.1——
Up moveDown movePending
AI summary
CARE Ratings upgraded Hester Biosciences ratings on 27 Aug 2026 based on FY26 audited and Q1FY27 unaudited results. Long-term bank facilities upgraded from BBB; Stable to BBB+; Stable. Short-term facilities upgraded from A3+ to A2. Long-term/Short-term combined facilities upgraded from BBB; Stable/A3+ to BBB+; Stable/A2. Total rated facilities stand at Rs 113.67 crore, with long-term amount reduced from Rs 66.25 crore to Rs 48.45 crore.
Likely market impact
Positive — signals stronger creditworthiness, may lower borrowing costs and boost investor confidence.